About
Palette Life Sciences is a medical device and life sciences company based in Santa Barbara, California. Founded in 2018 in Solna, Sweden, the company focuses on developing advanced medical solutions in urology, urogynecology, colorectal conditions, radiotherapy, and interventional oncology. With around 155 employees, Palette Life Sciences generates an estimated annual revenue of $38.9 million. The company specializes in creating innovative treatments for uncommon or challenging conditions, offering products like Barrigel®, a spacer that reduces radiation exposure during prostate cancer therapy, and Deflux® and Solesta®, both NASHA-based tissue bulking agents for treating pediatric vesicoureteral reflux and fecal incontinence, respectively. Palette Life Sciences serves healthcare professionals, including urologists and oncologists, with a commitment to improving patient outcomes through minimally invasive treatment options. In 2023, the company was acquired by Teleflex to enhance its urology portfolio and leverage its unique technologies.
Technologies
Keywords
Company Information
- Employees30
- Founded2018
- Annual Revenue$15000000
- Total Funding$148300000
Location
2A Fogdevreten, Gothenburg, Vaestra Goetaland County, Sweden, 171 65
